We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Endomagnetics in £2.1m Fund Raising
News

Endomagnetics in £2.1m Fund Raising

Endomagnetics in £2.1m Fund Raising
News

Endomagnetics in £2.1m Fund Raising

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Endomagnetics in £2.1m Fund Raising"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

All the existing investors took part in the latest Series B round: New Wave Ventures, Sarum Capital, UCL Business and Sussex Place Ventures. This brings the total raised by the Company to date to £4.6 million ($7m US).

Endomagnetics has been ramping up sales through Sysmex, its recently appointed distributor for the EMEA region, and new partnerships are being created with hospitals and clinics looking to adopt a more efficient and effective method for sentinel lymph node localisation - a key procedure in breast cancer diagnosis and treatment. Endomagnetics’ SentiMag® system uses advanced sensing technology to detect the location of injected Sienna+® tracer material, eliminating the need for the short-life radioactive alternatives in use today.

“We are delighted that all our investors have demonstrated their continued support for the business through this further fund raising”, said CEO of Endomagnetics Dr Eric Mayes. “Reaction of clinicians to our SentiMag® product has been most enthusiastic.”

Advertisement